FDA Inspection 1220651 — Lindsay Harrison, MD
The FDA completed an inspection of Lindsay Harrison, MD on Oct 5, 2023 in Austin, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 5, 2023
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Austin, TX (United States)
Additional Details
Clinical Investigator (CI)